Total Visits

Views
A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection10

Select a period of time:

Views

Views
November 20231
December 20231
January 20241
February 20241
March 20241
April 20240
May 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
 

Top cities views

Views
Boardman2
Ashburn1
Chicago1